Professor Declan Murphy & Dr Renu Eapen
GU Cast | Urology Podcast
A urology podcast, focussing on prostate cancer, kidney cancer, bladder cancer, testis and penile cancer. Join Professor Declan Murphy and Dr Renu Eapen from Peter MacCallum Cancer Centre in Melbourne for this regular dive into the world of genitourinary (GU) Oncology and Urology. Regular guests from all over the world, from every walk of life. Find out more gucast.org
Be sure to visit the podcast's website and support the creator: www.gucast.org
Author
Professor Declan Murphy & Dr Renu Eapen
Category
Podcast website
Latest episode
Nov 3, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
China focus - cardiovascular disease and prostate cancer 03.11.2026 25:28
Another of our special episodes with our Chinese team. We are joined by our Associate Editor for China, Yige Bao (SCU Hospital Xiamen, Xiamen City), and Junlong Zhang (Drum Tower Hospital, Nanjing), to discuss the topic of cardiovascualr disease in patients starting treatment for advanced prostate cancer. Some great practical advice on risk stratification for men starting intensified hormonal ther...
Journal Club | Intermittent hormonal therapy and open vs robot cystectomy 01.11.2026 35:39
Two fantastic topics on the GU Cast Journal Club today. The classic SWOG study of continuous vs intermittent hormonal therapy (NEJM 2013), and the RCT of open vs robotic radical cystectomy (JAMA 2022). Everything you need to bluff your way on these classic papers in a bite-sized podcast, led by our GU Cast Journal Club Editors, Elena Berg and Gaetan Devos, with our usual GU Cast Hosts Renu Eapen a...
#ERUS26 Live Robotic Surgery Spectacular from Padua 15.10.2026 1:06:05
A bumper episode bringing you some amazing highlights from the world's top live robotic urology meeting! We are once again at the EAU Robotic Urology Section Annual meeting, this year in Padua, Italy, featuring more than 50 live robotic urology surgeries, a large number of which are international telesurgeries - surgeons in Padua and patients in faraway countries. Get a close look at how this...
Ben & Sam's robotic surgery tech tour | #ERUS26 22.09.2026 28:25
Check out Join Ben Challacombe (Guy’s Hospital, London), and Sam Davies (Mater Hospital, Brisbane), as they take Declan Murphy for a tour of the incredible robotic surgery technology at the EAU Robotic Urology Section (ERUS) meeting in Padua. The largest ever collection of robotic surgery devices at the world’s best urology live surgery meeting. A bonus preview episode ahead of our main #ERUS26 h...
PLND for prostate cancer | Yes/No/Maybe?! With Briganti and Maurer 03.09.2026 22:33
Pelvic lymph node dissection (PLND) - one of our perennial favourite and contentious topics on GU Cast. Today we have both Alberto Briganti (Milano, ITA), and Tobias Maurer (Hamburg, GER), in the studio. Two hugely experienced prostate cancer surgeons, both with huge expertise in PLND. Alberto's name synomous with PLND due to the eponymous nomograms he has deveoped over the years. And Tobias...
Journal Club | DETECT haematuria trial and the post-prostatectomy radiotherapy trials 01.09.2026 30:23
Two great topics on the GU Cast Journal Club today. How should we image patients with haematuria (the DETECT trial, J Urol 2018), and what is the role of adjuvant vs salvage radiotherpay following radical prostatectomy (three great trials - RAVES, RADICALS and GETUG-AFU 17), see links below). Plus we welcome new GU Cast co-Editor Gaetan Devos, who recently joined us on Fellowship at Peter Mac, rep...
Widespread welcome for new Aussie prostate cancer guidelines 20.08.2026 45:07
The perennially thorny topic of prostate cancer screening has been very well addressed in the brand new Australian guidelines for the Early Detection of Prostate Cancer which we are delighted to highlight today. Pragmatic, progressive and patient-focused, are some of the comments we have read - great to hear! We have been very gratified to see the very positive reception which these guidelines h...
Advanced prostate cancer in a large urology group practice 09.08.2026 42:08
Urologist Ben Lowentritt (Chesapeake Urology, Baltimore), pops into the studio today while passing through Melbourne. We chat about life in a large urology group practice (a huge part of urology service delivery in the USA), why there appears to be a drop in interest in Fellowship training, and his experience of managing advanced prostate cancer in a large urology group practice. Ben, who is also...
Journal Club | Randomised surgical trials that did not change practice! 24.07.2026 40:00
Open vs partial nephrectomy, and open vs robotic prostatectomy - two large randomised trials that did not change surgical practice! Just as important to examine these in GU Cast Journal Club as to examine pivotal trials that did change practice. Today we discuss the EORTC Today we discuss the EORTC 30904 RCT looking at kidney cancer surgery (Eur Urol 2011), and the Brisbane randomised trial of ope...
ARASEC - Rethinking clinical trial design 15.07.2026 26:34
Welcome back Rana McKay! Renu was on a flight to Europe this week so Rana jumped into her seat in the GU Cast studio this week to have a chat about the intriguing ARASEC trial which she presented at the AUA Annual Meeting recently. Plus her thoughts on the ARACOG data presented at ASCO last month. And then a great chat with our other studio guest, Professor Renea Taylor, translational scientist at...
Timing, touch & technique: Batting lessons for nerve-sparing radical prostatectomy | With Ash Tewari 12.07.2026 29:48
Tips and tricks for nerve-sparing surgery, learned over 25 years of performing robotic radical prostatectomy. Today we are joined by Dr Ash Tewari, Chief of Urology at Mt Sinai (New York), to talk about his favourite topic - nerve-sparing surgery - and a little about his second favourite topic - cricket! Ash has been one of the world's foremost experts in robotic prostatectomy having been the...
Berlin Masterclass | Advanced prostate cancer 29.06.2026 32:53
Hot topics in a hot city!! Declan and Renu escaped from deep Winter in Melbourne and landed into the hottest day on record in Berlin!! We are here to help with the Astellas Global Prostate Cancer Masterclass, a wonderful two day meeting focussing on advanced prostate cancer. Delegates from all over the world and a top class local and International faculty. We catch up with great friends of GU Cast...
EV-pembro in localised and advanced bladder cancer - a superb summary! 24.06.2026 32:44
All you need to know about enfortumab vedotin (EV) & pembro in bladder cancer in 25 minutes! We are joined in studio by bladder cancer gurus Shilpa Gupta (Cleveland Clinic, USA) and Andrew Weickhardt (Austin Health, AUS) to get an update on the role of EV-pembro in both muscle-invasive localised bladder cancer, and metastatic bladder cancer. Shilpa led a very nice paper in this month's Eu...
Testis cancer and miR-371 - all you need to know! 20.06.2026 24:53
Yep it's been a buzz word in testis cancer for a while now, but with the read-out of the CLIMATE and SWOG 1823 trials in the past six months, we thought we better get ourselves updated on this exciting biomarker. We are joined in studio by testis cancer gurus Ben Tran (Medical Oncologist, Peter MacCallum Cancer Centre, Melbourne), and online by Aditya Bagrodia (Urologist, UCSD, San Diego), to...
Journal club #8 | PROTECT and EV-301 13.06.2026 22:35
Welcome to Episode 8 of our monthly GU Cast Journal Club! Today we focus on two very important papers in localised prostate cancer and metastatic bladder cancer. The landmark 15 year update of the PROTECT trial, published in NEJM in 2023, and the breakthrough EV-301 trial which heralded enfortumab vedotin in progressive metastatic bladder cancer, published in NEJM in 2021. We are delighted to welc...
Bayer Apex comes to Melbourne! 09.06.2026 25:49
Renu had been to an excellent Bayer Apex meeting in Europe in the past, so was very happy to hear Apex was coming to us for its first Asia-Pacific outing! A wonderful prostate cancer Faculty headlined by Neal Shore, Dan George, Derya Tilki, Fred Saad, Amit Bahl, Tamim Niazi to name but a few, plus almost 200 delegates from across the APAC region. Your usual hosts Renu Eapen and Declan Murphy catc...
Did PROTEUS just change Urology?? 31.05.2026 39:20
Breaking News podcast just after the long-awaited PROTEUS trial reads out at the ASCO Plenary in Chicago! Plus a simultaneous NEJM paper! Huge day for prostate cancer surgery. Declan and Renu are joined by lead author Dr Mary-Ellen Taplin (Dana Farber Cancer Institute & Harvard University), to tell us about her decades long journey to this huge moment today. PROTEUS is a huge (2,100 men) phas...
ARASEC and Lead-in ADT - China focus 17.05.2026 32:28
Two interesting papers caught the eye of our GU Cast China team this week; the first is the ARASEC trial which Dr Rana McKay read out in the Practice-Changing Plenary at the AUA Annual Meeting in Washington. This is an interesting comparison of ADT + darolutamide for mHSPC in a prospective US cohort, compared with an historical ADT-only control arm from CHAARTED. Interesting study design and inte...
Is Copper the new Gold??! Co-PSMA trial in European Urology 23.04.2026 27:25
Now this is an interesting one, a new PSMA tracer which appears to greatly outperform 68Ga-PSMA-11 for biochemical recurrence. We discuss 64Cu-SAR-bisPSMA with Professor Louise Emmett (Nuclear Medicine Physician, Sydney), and Dr Matt Roberts (Urologist, Brisbane), which they compared head to head with trusty old 68Ga-PSMA-11 in the Co-PSMA trial, just published in European Urology. With usual host...
EAU Prostate Cancer Guideline Update 12.04.2026 28:37
One of our most popular podcasts every year is when we chat with EAU Guideline gurus Derya Tilki and Gianluca Giannarini about the latest updates to the EAU Prostate Cancer Guideline. It is a 250 word document which is updated in March every year and changes are eagerly awaited around the world. We catch up with Derya (Vice Chair of the Prostate Cancer Guidleine Committee) in person in Melbourne,...
Journal club #7 | proPSMA and Penile Fractures(!) 06.04.2026 28:09
Democracy in action! This month's GU Cast Journal Club papers were chosen by an audience vote at our GU Cast Live Event at EAU in London. Therefore today we focus on first, the landmark proPSMA paper which established the superior accuracy of PSMA PET/CT for staging unfavourable intermediate and high-risk prostate cancer (Lancet 2020). Then for something completely different, we dig out a pap...
ASPIRE-ing to answer the Triplet question! With Rana McKay and Deepak Kilari 02.04.2026 25:11
The trial they said would never be done! Huge congrats to the Alliance for Clinical Trials in Oncology who have recently opened the ASPIRE trial, a phase III randomised trial of ADT + apalutamide (doublet), vs ADT + apalutamide + docetaxel chemotherapy (triplet) for men with mHSPC. 1200 men will be recruited from more than 300 sites across the US with many sites already open and recruiting. This i...
From Studio to Stage: GU Cast Live at EAU in London! 20.03.2026 41:13
Our biggest live show to date! Taking to the huge eUro 2 auditorium at this month's EAU Annual Meeting in London, Declan and Renu bring you a fast-paced, high-energy session packed with favourite guests, controversial topics, behind-the-scenes stories, and lots of great giveaways, all boosted by having hundreds of our loyal supporters there in the audience with us. Huge thanks to Maarten Albe...
PRIMARY 2 is positive! PSMA PET/CT moves to early detection 13.03.2026 33:44
Big day at the EAU Annual Meeting n London today, as our colleague Dr James Buteau (Nuclear Medicine Physician, Peter MacCallum Cancer Centre, Melbourne), reads out the PRIMARY 2 RCT at the Practice-Changing Plenary in London. Plus a simultaneous publication in Lancet Oncology. Big news for the early detection of prostate cancer, especially for patients with normal or equivocal MRI scans. Declan...
Histolog digital microscopy | All you need to know! 08.03.2026 38:01
We bring you highlights from a fantastic two day meeting at the ORSI Academy in Belgium, focussing on the hot topic of intra-operative margin assessment (IOMA), especially during prostate cancer surgery. Following on from the publication of the Neurosafe Proof RCT last year, there has been a surge in interest in new technologies to facilitate IOMA, in particular the Histolog confocal laser microsc...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.